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RV Electrical Activation in Heart Failure During
Right, Left, and Biventricular Pacing*
Martin Bernier, MD, Mark E. Josephson, MD
Boston, MassachusettsRight Ventricular (RV) Activation Mapping for
Patients With Heart Failure: Back to the Basics
Since its approval by the U.S. Food and Drug
Administration in 2001 for selected patients with
systolic dysfunction, cardiac resynchronization
therapy (CRT) has generated tremendous interest
and a large body of literature. The mere idea of
addressing the maladaptive electrical phenomena
associated with heart failure and their hemody-
namic consequence seems logical but has been
See page 567
fraught with limitations. For those who respond,
the potential benefits of improved quality of life,
New York Heart Association functional class, and
hemodynamic and echocardiographic parameters
such as left ventricular (LV) dimensions and LV
ejection fraction have been well documented.
Unfortunately, identification of general inclusion
criteria for patients likely to benefit from CRT has
been generally disappointing. Most trials have been
plagued with 30% of nonresponders and often
more. The reasons for such a high rate of failure
may involve a number of factors, namely, the
heterogeneity of the population of patients, the
ischemic versus nonischemic nature of cardiomyop-
athy, the incomplete correlation between electro-
cardiographic findings and the presence of mechan-
ical dyssynchrony, and technical factors such as
programming and lead positioning at the time of
implantation.
Particularly interesting are the findings of im-
proved LV dimensions or ejection fraction without
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC Cardio-
vascular Imaging or the American College of Cardiology.From Beth Israel Deaconess Medical Center, Boston, Massachusetts.consistent correlation with improved New York
Heart Association functional class. A number of
trials, such as REVERSE (REsynchronization re-
VErses Remodeling in Systolic left vEntricular
dysfunction) (1) and PROSPECT (Predictors of
Response to Cardiac Resynchronization Therapy)
(2,3), illustrate the difficulty in using LV echocar-
diographic parameters to predict the response to
CRT. The reasons for that are potentially many, as
mentioned previously. It remains a constant, how-
ever, that there is no reliable way to predict suc-
cessful CRT. In the ongoing quest to improve CRT
and decrease the large proportion of nonresponders,
there has been growing interest in looking at RV
parameters during CRT. Could the right ventricle
be a significant player in the clinical evolution of
patients with LV systolic heart failure?
In this issue of iJACC, Varma et al. (4) present a
comparison of RV activation during intrinsic con-
duction and ventricular pacing. Patients with sys-
tolic heart failure and cardiac resynchronization
devices were compared with healthy control sub-
jects. Measure of the rS duration was used as a
surrogate measure of intact right bundle branch
conduction. Patients with native right bundle con-
duction, owing to native atrioventricular conduction
(in the control population) or to careful program-
ming of timed LV pacing, generally had a shorter
RV activation time, as defined by electrocardio-
graphic imaging. This benefit persisted when they
were compared with patients who were paced in the
right ventricle or had biventricular pacing pro-
grammed.
It seems intuitive that using the specialized car-
diac conduction tissue to depolarize the right ven-
tricle would lead to a more rapid and organized RV
activation compared with the slow concentric cell-
to-cell activation that follows myocardial pacing
from an RV apical site. In this regard, this work is
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577eminiscent of previous ex vivo models and in vivo
tudies performed by our team using direct intra-
perative measurements of ventricular depolariza-
ion. Patterns of propagation of the depolarization
avefront and breakthrough from the His-Purkinje
ystem have been documented in patients with
ormal conduction systems or bundle branch block
5). These studies have taught us the association
etween electrical conduction and organized me-
hanical activation of the ventricles.
The interest of the work by Varma et al. (4) is
hat it attempts to link mechanistic work and its
linical implications and substantiates the potential
echanism for the deleterious effect of RV pacing
n patients who do have native right bundle con-
uction, via a noninvasive novel approach.
It is appealing to conclude that a shorter RV
ctivation duration will be beneficial to patients.
iven the incomplete correlation between electrical
nd mechanical events, concluding that a shorter
V activation time will translate into improved
unction is a leap of faith that we cannot make.
Although we know that long-term RV apical
acing is probably detrimental to LV function, little
s known about the long-term effects of isolated LV
acing on RV function or other parameters such as
V dimensions. The concerns over the potential for
yocardial remodeling also remain. In the end, one
uestion that will arise is whether timed LV pacing
ill be associated with any adverse long-term effect
n the left ventricle.
We know that the population of patients with
eart failure is very heterogeneous. In the study by
arma et al. (4), only 1 patient had a dilated right
entricle. RV involvement as a consequence of LV
ystolic failure is a common occurrence. One can
nly wonder whether a similar study in patients. Bax JJ, Gorcsan J III. Echocardiogra-
phy and noninvasive imaging in cardiac Img 2009;3:567–75olving the terminal right bundle branch could lead
o different conclusions.
Obviously, the conclusions of a small study such
s the one presented here should be used as a proof
f concept and for hypothesis generation. The good
orrelation of electrocardiographic imaging with
revious invasive measures of ventricular activation
s an interesting finding that suggests that we may
e able to use this new tool when tailoring CRT in
ndividual patients. Perhaps it will turn out that
imed LV pacing will prove to be superior to
iventricular pacing in a selected population of
atients.
At a time when we are dealing with rapidly
ncreasing health care costs, any tool that would
elp to better tailor therapy and identify patients
ho are likely to benefit from CRT is welcome.
ecent trials such as MADIT-CRT (Multicenter
utomatic Defibrillator Implantation Trial With
ardiac Resynchronization Therapy) (6) have
ooked at extending the application of CRT devices
o a wider population of patients with mitigated
esults. We need to do better in selecting patients
or CRT.
It might just be that there are no universal
eneral criteria that can identify patients who will
enefit from CRT. The work presented in this issue
f iJACC has the merit of bringing the focus back to
he level of the mechanism and to potentially add a
seful noninvasive tool to the armamentarium avail-
ble with which to identify patients who will benefit
rom CRT.
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